REPL has been in a prolonged downtrend, but appears to have finally put in a long-term bottom near its all-time low of $1.50. Price has since broken and successfully retested a major trendline resistance — a structurally bullish sign that suggests the worst may be behind it.
The bias is now bullish as long as price holds above $8.50 on a daily closing basis.
🎯 Target: $17
🛑 Invalidation: Daily close below $8.50
Fundamental Catalyst:
REPL is a clinical-stage biotech developing oncolytic immunotherapies. Its lead drug RP1 targets advanced melanoma patients who have failed PD-1 therapy — a high unmet need space. The FDA recently issued a second CRL, which is a setback, but the market is clearly pricing in a path forward. Importantly, the company has cash runway extended into Q1 2027, reducing dilution risk near term.
This is a high-risk / high-reward catalyst play — any positive FDA development could be a major upside trigger.
The bias is now bullish as long as price holds above $8.50 on a daily closing basis.
🎯 Target: $17
🛑 Invalidation: Daily close below $8.50
Fundamental Catalyst:
REPL is a clinical-stage biotech developing oncolytic immunotherapies. Its lead drug RP1 targets advanced melanoma patients who have failed PD-1 therapy — a high unmet need space. The FDA recently issued a second CRL, which is a setback, but the market is clearly pricing in a path forward. Importantly, the company has cash runway extended into Q1 2027, reducing dilution risk near term.
This is a high-risk / high-reward catalyst play — any positive FDA development could be a major upside trigger.
📊 Charts → 🏗️ Structure → 🎯 Probability =📖 Chart Story
⏳ Patience → 🚀Success
🎯 If this setup makes sense to you, show it some support with a Boost.
⏳ Patience → 🚀Success
🎯 If this setup makes sense to you, show it some support with a Boost.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
📊 Charts → 🏗️ Structure → 🎯 Probability =📖 Chart Story
⏳ Patience → 🚀Success
🎯 If this setup makes sense to you, show it some support with a Boost.
⏳ Patience → 🚀Success
🎯 If this setup makes sense to you, show it some support with a Boost.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.